FDA approves Lupin’s HIV-1 generic

MUMBAI, India — Lupin announced its Abacavir and Lamivudine tablets, 600 mg/300 mg, received Food and Drug Administration approval. Lupin’s Abacavir and Lamivudine tablets, 600 mg/300 mg, are the AB rated generic equivalent of ViiV Healthcare’s Epzicom tablets, 600 mg/300 mg. It is indicated in combination with other antiretroviral agents for the treatment of HIV-1 infection.



Epzicom tablets had sales of $388.1 million (IMS MAT December 2016).